Published this month in PLOS Pathogens, microbiologists at Stanford and the University of Oregon found that acid-reducing proton pump inhibitors, or PPIs, such as omeprazole, commonly sold under the brand name Prilosec, may encourage the spreading of a bacterium that is linked to stomach cancer. “Helicobacter pylori is a bacterium that chronically infects the stomachs of 50 percent of humans, and infection can lead to serious diseases like peptic ulcers and stomach cancer,” say the study authors. “Stanford microbiologist Manuel Amieva, MD and his colleagues identified receptors H. pylori uses to detect and flee the detested acidity of its chosen ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.